中药复方旋复代赭汤合左金丸干预胃食管反流病的疗效  被引量:3

Efficacy of Xuanfudaizhe Decoction in combination with Zuojin Pill in the treatment of gastroesophageal reflux disease

在线阅读下载全文

作  者:王其进[1] 吴仕文[1] 陈景利[2] 黄寅銮[3] 

机构地区:[1]海南省中医院,海南省海口市570100 [2]广东省佛山市中医院,广东省佛山市528000 [3]广东省深圳市宝安区中医院,广东省深圳市518000

出  处:《世界华人消化杂志》2010年第26期2812-2815,共4页World Chinese Journal of Digestology

摘  要:目的:探讨旋复代赭汤合左金丸干预胃食管反流病的临床疗效.方法:符合纳入标准、诊断标准及不符合排除标准的胃食管反流病患者120例,按1∶1随机分为两组;治疗组予旋复代赭汤合左金丸颗粒剂干预4wk,对照组予兰索拉唑胶囊干预4wk.观察分析患者胸痛、胸骨后烧灼感等症状及胃镜变化.结果:治疗前,两组患者基线资料分析,无统计学差异,具有可比性;予不同药物干预4wk,胸痛、胸骨后烧灼感及内镜下食管糜烂积分均呈下降趋势,两组患者治疗前、后胃镜积分比较无统计学差异;两组治疗后胸痛,胸骨后烧灼感均明显好转(均P<0.05).其中治疗组总有效率为90.00%,对照组总有效率为86.66%,两组总体疗效比较无统计学差异.结论:旋复代赭汤合左金丸具有明确改善内镜下食管糜烂,缓解胸痛、胸骨后烧灼感等症状,疗效与兰索拉唑相似,值得临床推广应用.AIM: To investigate the efficacy of Xuanfudaizhe Decoction in combination with Zuojin Pill in the treatment of gastroesophageal reflux disease (GERD). METHODS: One hundred and twenty patients with GERD were randomly and equally divided into two groups: intervention group and control group. The intervention group was treated with Xuanfudaizhe Decoction in combination with Zuojin Pill for 4 wk, while the control group was treated with lansoprazole for the same duration. The clinical and endoscopic manifestations of esophageal mucosal lesions in these patients were then observed. RESULTS: Before treatment, there is no significant difference in baseline data between the two groups. After treatment for 4 wk, the scores of chest pain and heart-burn and endoscopic manifestations of esophageal mucosal erosion declined in both groups. No significant difference was observed in the total response rate between the intervention group and control group (90% vs 86.66%, P 0.05). CONCLUSION: Xuanfudaizhe Decoction in combination with Zuojin Pill has comparable efficacy to lansoprazole in the treatment of GERD.

关 键 词:旋复代赭汤 左金丸 胃食管反流病 临床研究 

分 类 号:R259[医药卫生—中西医结合]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象